Limited-sampling strategies for anidulafungin in critically ill patients. - Wikidata - wikimedia - TriplyDB

Limited-sampling strategies for anidulafungin in critically ill patients.

Limited-sampling strategies for anidulafungin in critically ill patients.

http://www.wikidata.org/entity/Q35105939

about

Pharmacokinetic study of anidulafungin in ICU patients with intra-abdominal candidiasis.Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation.

P2860

Q39020129-CC883672-AC12-4D8E-855E-261651CFBDE3 Q54957028-6A529FB5-D88C-4707-8E00-EF5B01D5DB78

P2860

Limited-sampling strategies for anidulafungin in critically ill patients.

http://www.wikidata.org/entity/Q35105939

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Limited-sampling strategies for anidulafungin in critically ill patients.

@ast

Limited-sampling strategies for anidulafungin in critically ill patients.

@en

type

label

Limited-sampling strategies for anidulafungin in critically ill patients.

@ast

Limited-sampling strategies for anidulafungin in critically ill patients.

@en

prefLabel

Limited-sampling strategies for anidulafungin in critically ill patients.

@ast

Limited-sampling strategies for anidulafungin in critically ill patients.

@en

P1433

Q35105939-66B87586-5224-4C6E-9889-16F79F35D56A

P1476

Q35105939-5FE7EBCF-1F33-48F2-9629-8EB0D81DFF1A

P2093

Q35105939-07BFB0CC-7D78-41D9-9F8E-ABFD25E9B6D1

Q35105939-449AF315-8D22-4146-BB20-58A6F961DA5F

Q35105939-50D36E06-E0EF-46F5-8520-FC0A369A4602

Q35105939-5748BD63-98F7-4F4E-B807-E376E73289BC

Q35105939-97DA1F0E-80F6-40F5-98EB-6E3F3611A99D

Q35105939-AD7E0CF0-FADA-4244-A5E2-7141E10667F8

Q35105939-DDE1B84F-4C9C-4232-9739-21122AA43717

P2860

Q35105939-349188D9-F1A0-4C38-989B-EA5EC6BD604E

Q35105939-38C5D08C-B242-4367-B290-37ACA906008E

Q35105939-3F729D19-D06B-4E53-8DDC-BF930E41AA51

Q35105939-602130E6-8F25-4919-BAC4-BF02E94ECB6A

Q35105939-69416DD8-39D2-4F40-A78F-7309A1C086EE

Q35105939-69CC2D75-16ED-4865-A34E-AE4D9F85E2F8

Q35105939-86E09696-3284-41B9-9100-03C74AC4FE72

Q35105939-B71ABBF0-3C84-4606-AEBE-5D16DD78A6BF

Q35105939-D3EC5EE4-3222-4E14-AA54-9920FAF313D2

Q35105939-D7727414-E0E1-424E-8F7D-964BC3CF3EB0

P304

Q35105939-C09D2464-2BCC-4611-981C-035FDA467990

P31

Q35105939-0B3D8CB9-BF7F-471B-9C42-FE8B166F741B

P356

Q35105939-C0CBD4AC-D61E-42BE-BC5C-A1EA14D550A6

P407

Q35105939-23D5E18D-8A9B-49BB-847F-91BAE57A430D

P433

Q35105939-7E6C0C43-20F0-493D-ABF8-F9FA1D632B39

P478

Q35105939-36F79620-7ED1-406A-B996-31DAC10996C4

P50

Q35105939-CDEE9C8A-B4C3-47CE-B10E-A50F125722F1

P577

Q35105939-4D14C454-D0D9-48CE-B4B2-6B59D49B3774

P698

Q35105939-789544F0-C732-46F0-BEEE-506E42398199

P932

Q35105939-E6C9477C-0FBC-47E7-8521-8FF51693A362

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Limited-sampling strategies for anidulafungin in critically ill patients.

@en

P2093

Donald R A Uges

http://www.w3.org/2001/XMLSchema#string

Jan G Zijlstra

http://www.w3.org/2001/XMLSchema#string

Jan-Willem C Alffenaar

http://www.w3.org/2001/XMLSchema#string

Johannes H Proost

http://www.w3.org/2001/XMLSchema#string

Jos G W Kosterink

http://www.w3.org/2001/XMLSchema#string

Marjolijn J P van Wanrooy

http://www.w3.org/2001/XMLSchema#string

Michael G G Rodgers

http://www.w3.org/2001/XMLSchema#string

P2860

Performance of an iterative two-stage bayesian technique for population pharmacokinetic analysis of rich data sets.

What do we mean by validating a prognostic model?

In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species.

Pharmacokinetics/pharmacodynamics of echinocandins.

In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model.

Pharmacokinetics of anidulafungin in critically ill patients with candidemia/invasive candidiasis

Low but sufficient anidulafungin exposure in critically ill patients.

Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.

Anidulafungin for Candida glabrata infective endocarditis.

Simultaneous quantification of anidulafungin and caspofungin in plasma by an accurate and simple liquid chromatography tandem mass-spectrometric method.

P304

1177-1181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.03375-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Tjip S van der Werf

P577

2014-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25487797

http://www.w3.org/2001/XMLSchema#string

P932

4335880

http://www.w3.org/2001/XMLSchema#string